1. Home
  2. BHVN vs CTS Comparison

BHVN vs CTS Comparison

Compare BHVN & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • CTS
  • Stock Information
  • Founded
  • BHVN 2013
  • CTS 1896
  • Country
  • BHVN United States
  • CTS United States
  • Employees
  • BHVN N/A
  • CTS N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • CTS Electrical Products
  • Sector
  • BHVN Health Care
  • CTS Technology
  • Exchange
  • BHVN Nasdaq
  • CTS Nasdaq
  • Market Cap
  • BHVN 1.4B
  • CTS 1.3B
  • IPO Year
  • BHVN 2017
  • CTS N/A
  • Fundamental
  • Price
  • BHVN $13.50
  • CTS $41.42
  • Analyst Decision
  • BHVN Strong Buy
  • CTS
  • Analyst Count
  • BHVN 14
  • CTS 0
  • Target Price
  • BHVN $58.85
  • CTS N/A
  • AVG Volume (30 Days)
  • BHVN 1.6M
  • CTS 275.1K
  • Earning Date
  • BHVN 08-07-2025
  • CTS 07-24-2025
  • Dividend Yield
  • BHVN N/A
  • CTS 0.39%
  • EPS Growth
  • BHVN N/A
  • CTS 18.55
  • EPS
  • BHVN N/A
  • CTS 2.11
  • Revenue
  • BHVN N/A
  • CTS $520,937,000.00
  • Revenue This Year
  • BHVN $3.00
  • CTS $4.41
  • Revenue Next Year
  • BHVN $59.97
  • CTS $7.00
  • P/E Ratio
  • BHVN N/A
  • CTS $19.63
  • Revenue Growth
  • BHVN N/A
  • CTS 1.12
  • 52 Week Low
  • BHVN $13.04
  • CTS $34.02
  • 52 Week High
  • BHVN $55.70
  • CTS $59.68
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 42.74
  • CTS 47.10
  • Support Level
  • BHVN $13.30
  • CTS $40.07
  • Resistance Level
  • BHVN $14.09
  • CTS $43.88
  • Average True Range (ATR)
  • BHVN 0.82
  • CTS 1.21
  • MACD
  • BHVN 0.05
  • CTS -0.15
  • Stochastic Oscillator
  • BHVN 19.74
  • CTS 31.25

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

Share on Social Networks: